Michael Pfreundschuh

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

Michael Pfreundschuh, Lorenz Trümper, Anders Österborg et al. · The Lancet Oncology · 2006 · 2.1K citations

Hematological Malignancy, Lymphoid Neoplasia, Mabthera International Trial +7

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

Bjoern Chapuy, Chip Stewart, Andrew Dunford et al. · Nature Medicine · 2018 · 1.9K citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Molecular Subtypes +8

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

Yao‐Tseng Chen, Matthew J. Scanlan, Uğur Şahin et al. · Proceedings of the National Academy of Sciences · 1997 · 1.2K citations · Full text

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

Michael Pfreundschuh, Jöerg Schubert, Marita Ziepert et al. · The Lancet Oncology · 2008 · 1.1K citations

Hematological Malignancy, Lymphoid Neoplasia, Elderly Patients +7

Human neoplasms elicit multiple specific immune responses in the autologous host.

Uğur Şahin, Ö. Türeci, Holger Schmitt et al. · Proceedings of the National Academy of Sciences · 1995 · 1.1K citations · Full text

Immunology, Pathology, Escherichia Coli +18